$ASTC Completed Successful 1st Detect Demo with DHS and TSA Personnel

AUSTIN, Texas

Astrotech Corporation (NASDAQ: ASTC) is excited to announce that – following a successful demonstration with Department of Homeland Security (DHS) and Transportation Security Administration (TSA) personnel – 1^st Detect’s TRACER 1000 MS-ETD will be available for demonstration at Astrotech’s annual meeting of shareholders, to be held on Dec. 7, 2017 at 9:00 a.m. CT at the JW Marriott, 110 E. 2^nd St., Austin, TX.

The TRACER 1000 is a mass spectrometry-based explosives trace detector (ETD), custom-developed for the TSA as an improvement over and replacement for the ion mobility spectrometry (IMS) ETD systems currently deployed at aviation checkpoints worldwide.

These antiquated IMS systems have many shortcomings – most notably their limited library of detectable compounds, inability to adapt to emerging threats, and significant false positive rates that extend security wait times. The TRACER 1000 overcomes all of these shortcomings, and also provides significant enhancements, including:

• Considerably expanded list of explosives, narcotics and other compounds of interest;
• Target library that can be instantaneously updated or expanded in the field without requiring hardware configuration changes;
• Near-zero false positive rates;
• Improved passenger satisfaction due to increased throughput at checkpoints; and
• Similar market cost to current IMS ETDs.

“We believe the TRACER 1000 will address the TSA’s current and future ETD needs, and we are excited to begin testing with the Department of Homeland Security’s Transportation Security Laboratory in the coming weeks,” said Thomas B. Pickens III, CEO of 1^st Detect and Astrotech. “The TRACER 1000 will significantly augment airport security by resolving the problems the TSA has with current IMS-based ETD systems. The demonstration of the TRACER 1000 at our annual meeting will showcase the results of years of investment, dedicated hard work, and numerous technological breakthroughs to enhance our nation’s security.”

About Astrotech

Astrotech Corporation (NASDAQ: ASTC) is an innovative science and technology company that invents, acquires, and commercializes technological innovations sourced from research institutions, laboratories, universities, and internally, and then funds, manages, and builds proprietary, scalable start-up companies for profitable divestiture to market leaders to maximize shareholder value. Sourced from Oak Ridge Laboratory’s chemical analyzer research, 1^st Detect develops, manufactures, and sells chemical analyzers for use in the security, defense, healthcare, food and beverage, and environmental markets. Sourced from decades of image research from the laboratories of IBM and Kodak, Astral Images sells film-to-digital image enhancement, defect removal and color correction software, and post processing services providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Sourced from NASA’s extensive microgravity research, Astrogenetix is applying a fast-track, on-orbit discovery platform using the International Space Station to develop vaccines and other therapeutics. Demonstrating its entrepreneurial strategy, Astrotech management sold its state-of-the-art satellite servicing operations to Lockheed Martin in August 2014. Astrotech has operations throughout Texas and is headquartered in Austin. For information, please visit www.astrotechcorp.com.

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

$DPW Subsidiary Coolisys Technologies Unveils Its First Cryptocurrency Hardware

Targets Popular Antminer Model S9 to Launch Power Product Line for Digital Miners

FREMONT, Calif., Dec. 04, 2017  — Digital Power Corporation (NYSE.American:DPW) (“Digital Power” or the “Company“), a company seeking to increase revenues through acquisitions and organic growth, announced today that its wholly owned subsidiary, Coolisys Technologies, Inc. (”Coolisys”), anticipates launching a line of advanced technology power systems for digital mining of cryptocurrencies, including Bitcoin and the other top digital currencies worldwide. Both digital mining as an industry and cryptocurrency as an asset class have experienced exponential growth for the past 5 years. Leveraging the Company’s 48 years of designing, manufacturing and receiving worldwide adoption of its highly efficient and durable power solutions and systems, Coolisys believes it is well positioned to resolve challenges with the cost and use of power for today’s burgeoning digital mining community and adopt and implement other technological improvements.

Coolisys stated that the first miner AC-DC switching power supply being produced will be for use by the Antminer S9 model by Bitmain Masters and can now be pre-ordered. The very popular and highly regarded Antminer S9 was the world’s first dedicated bitcoin miner using an application-specific integrated circuit, (commonly known as an ’ASIC’), based on the sixteen nanometer (“16nm”) process on its system. Coolisys noted the new product line was a result of the agreement with PoW Digital Mining previously announced on August 10, 2017, which said ‘PoW Digital Mining is to lead its development of an equipment and services portfolio targeting Digital Mining and related research and development of cryptocurrency. The active digital mining markets led by Bitcoin, Ethereum and the other 900+ digital currencies have created a budding hardware demand driving the need for efficient low-cost power solutions.’ PoW Digital Mining affirmed that the top issue for most professionals and amateurs who actively mine Bitcoin, Litecoin and other cryptocurrencies is energy costs. Cryptocurrency mining of block-chain transactions is power-hungry. The most successful miners are those that get the highest hash rates out of their systems, at the lowest total cost. Since electricity is the biggest on-going cost of mining, it follows that maximizing the efficiency of the power supply is critical. Even with the smallest of efficiencies delivering notable savings, PoW Digital Mining reported that a new line of crypto-mining power solutions within a suite of products could be readily commercialized.

Amos Kohn, President and CEO of Coolisys Technologies and Digital Power Corporation stated, “We have a competitive advantage given our expertise in developing and providing advance power solutions for the tech, military, industrial and healthcare sectors. To power the AntMiner S9, we will utilize our field-proven platform, previously implemented to power cloud-based computing networks and servers, that employ highly-efficient power switching with fully synchronous rectification and advanced digital signal processing (DSP). Our power solutions are based on next-generation design and we believe are among the most technologically advanced power processing solutions available. We project our cryptocurrency initiatives and products could have a material effect on the Company’s revenues and net income for this component of its operations during 2018. We look forward to presenting what we are developing.”

“When we first met with the Digital Power in 2016 and were becoming familiar with its long history of manufacturing advanced power solutions, we recognized that the Company was underutilizing its technical knowledge base and product development capabilities. Our investment strategy included our looking forward to harnessing and leveraging these assets to provide a range of new product portfolios and expanding the Company’s revenue streams. We look forward over the coming months that the marketplace will continue to appreciate the abilities and potential of DPW, its management and staff and its strategies to bring added-value to our shareholders,” commented Milton “Todd” Ault, III, the Company’s Executive Chairman.

Units may be pre-ordered at www.SuperCryptoPower.com with units shipping some time during the first quarter of 2018.

The Company reminds its shareholders, investors and the public it will issue an investor update before the opening of the market on the morning of December 7, 2017. Topics will include an update on revenue guidance for the quarter and 2018, a progress report on the cryptocurrency initiatives by Coolisys Technologies, advances made on the MTIX $50M purchase order and the advanced technology platform and an update on Digital Power Lending.

ABOUT DIGITAL POWER

Headquartered in Fremont, CA, Digital Power Corporation, through its subsidiaries, designs, manufactures and sells high-grade customized and off-the-shelf power system solutions. Our products are used in the most demanding communications, industrial, medical and military applications where customers demand high density, high efficiency and rugged power solutions. The Company’s wholly owned subsidiary, Coolisys Technologies, Inc., is dedicated to providing world-class technology-based solutions where innovation is the main driver for mission-critical applications and lifesaving services. Coolisys’ growth strategy targets core markets that are characterized by “high barriers to entry” and include specialized products and services not likely to be commoditized. Coolisys Technologies, Inc., a developer and manufacturer that services the defense, aerospace, medical and industrial sectors, has three subsidiaries including Digital Power Limited dba Gresham Power Ltd., www.GreshamPower.com, a manufacturer based in Salisbury, UK.; Microphase Corporation, www.MicroPhase.com with its headquarters in Shelton, CT 1-203-866-8000; and Power-Plus Technical Distributors, www.Power-Plus.com, a wholesale distributor based in Sonora, CA 1-800-963-0066.

Digital Power Lending, LLC, is a wholly owned subsidiary of the Company, is based in Fremont, CA, and is a California private lending company dedicated to strategically providing capital to small and middle size businesses for an equity interest in addition to loan fees and interest, www.DigitalPowerLending.com. Excelo, LLC, a wholly-owned subsidiary of the Company, is a national search firm specializing in fulfilling strategic executive, professional and hi-tech placements for businesses delivering world-class services, www.Excelo.com. Digital Power Corporation’s headquarters is located at 48430 Lakeview Blvd., Fremont, California, 94538; 1-877-634-0982; www.DigiPwr.com.

For Investor inquiries: IR@digipwr.com, www.DigitalPowerCorp.com or 1-888-753-2235.

Forward-Looking Statements

The foregoing release contains “forward looking statements” regarding future events or results within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements concerning the Company’s current expectations regarding revenues for the remaining 2017 and thereafter from contracts and operations on a consolidated basis, the ability of the Company to complete the manufacturing of its new product line for the digital mining community or the ability of the Company to sell digital mining power systems. The Company cautions readers that such “forward looking statements” are, in fact, predictions that are subject to risks and uncertainties and that actual events or results may differ materially from those anticipated events or results expressed or implied by such forward- looking statements. The Company disclaims any current intention to update its “forward looking statements,” and the estimates and assumptions within them, at any time or for any reason, unless required by applicable law. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.DigitalPowerCorp.com.

$PRKR Invited to Present Clarifications in German Infringement Case Against $AAPL

Court Rejects Apple’s Request for Bond

JACKSONVILLE, Fla., Dec. 01, 2017 — ParkerVision, Inc. (NASDAQ:PRKR), a developer, manufacturer and marketer of semiconductor technology solutions for wireless applications, announced today that the Munich court rejected the request by Apple, Inc. and certain of its’ subsidiaries that ParkerVision GmbH be required to post a bond as required of a non-German entity. The court has also informed ParkerVision GmbH that it is invited to provide further clarification regarding certain elements of infringement by Apple following the finalization of this decision.

A hearing was held on November 16, 2017 in this case during which both parties were allowed to present arguments regarding the alleged infringement, by Apple, of the German part of European Patent 1 135 853 (“the ‘853 Patent”).

Jeffrey Parker, CEO of ParkerVision, who attended the November 16^th hearing, stated, “I believe our counsel was able to thoroughly explain to the court our energy sampling technology as described in the ‘853 Patent and furthermore, how our energy sampling technology is clearly different from sample-and-hold technologies that the defendant cited as prior art.   Based on comments from the court during the hearing, we believe Apple presented oral arguments that conflicted with their written pre-hearing briefs.”

Parker continued, “We welcome the court’s request for additional information, as we believe further clarification will only strengthen our infringement position and enable the court to reach a swift decision.  We are working with German counsel to expedite the schedule for these next steps and anticipate that the court will continue to move at the same rapid pace that it has thus far.”

 About ParkerVision

ParkerVision, Inc. designs, develops and markets its proprietary radio-frequency (RF) technologies, which enable advanced wireless solutions for current and next generation communications networks. Currently developing several new products to enhance Wi-Fi connectivity for small businesses and consumers, ParkerVision has recently unveiled a family of products under the Milo™ brand that leverages existing Wi-Fi infrastructure to create more optimal Wi-Fi configuration and superior coverage.  For more information please visit www.parkervision.com. (PRKR-G)

Safe Harbor Statement

This press release contains forward-looking information.  Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made.  Such statements are subject to certain risks and uncertainties which are disclosed in the Company’s SEC reports, including the Form 10-K for the year ended December 31, 2016 and the Forms 10-Q for the quarters ended March 31, June 30, and September 30, 2017.  These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.

Contact:

Cindy Poehlman
Chief Financial Officer
ParkerVision, Inc.
904-732-6100
cpoehlman@parkervision.com

or

Laurie Little
The Piacente Group
212-481-2050
parkervision@tpg-ir.com

$ADMP Results of a Human Factors Study in Pre-filled Epinephrine at #AAAAI

SAN DIEGO, Dec. 01, 2017 — Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) announced today the acceptance of a presentation entitled “Human Factors Study of A Newly Approved Epinephrine Prefilled Syringe (Symjepi) for the Emergency Treatment of Allergic Reactions (Type I) Including Anaphylaxis”.  The presentation will be for the American Academy of Allergy, Asthma, and Immunology (AAAAI) joint congress with the World Allergy Organization and will be held in Orlando, Florida on March 3, 2018.   This premier annual educational event draws thousands of healthcare professionals including allergists, immunologists and other medical specialists.

Dr. Dennis J. Carlo, President/CEO of Adamis stated, “Symjepi was studied in trained and untrained adults, adolescents and caregivers.  The results definitively showed Symjepi to be an easy to use, small and intuitive device.”  Dr. Ronald Moss, Chief Medical Officer at Adamis and a Fellow of AAAAI stated, “For a layperson, treatment of anaphylaxis with a simple non-threatening device is critical to successful use.”  The presentation will focus on the successful human factors study utilizing Symjepi.

About Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. The company’s first product, Symjepi (epinephrine) Injection 0.3mg, was approved in June 2017 for use in the emergency treatment of acute allergic reactions, including anaphylaxis.  Adamis’ product pipeline includes HFA metered dose inhaler and dry powder inhaler products for the treatment of bronchospasm and asthma.
The Company’s U.S. Compounding, Inc. (USC) subsidiary, which is registered as a drug compounding outsourcing facility under Section 503B of the U.S. Food, Drug & Cosmetic Act and the U.S. Drug Quality and Security Act, compounds sterile prescription drugs, and certain nonsterile drugs, to patients, physician clinics, hospitals, surgery centers and other clients throughout most of the United States.

Adamis Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements relate to future events or future results of operations, including, but not limited to the following statements: the status of anticipated presentations by the company at upcoming conferences; the company’s beliefs concerning the ability of its products and product candidates to compete successfully in the market; the company’s beliefs concerning the results of studies relating to Symjepi and user perceptions of Symjepi; and the company’s beliefs concerning the safety and effectiveness of its products and product candidates.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause Adamis’ actual results to be materially different from those contemplated by these forward-looking statements.  Certain of these risks, uncertainties, and other factors are described in greater detail in Adamis’ filings from time to time with the SEC, which Adamis strongly urges you to read and consider, all of which are available free of charge on the SEC’s web site at http://www.sec.gov.  Any forward-looking statement in this press release speaks only as of the date on which it is made.  Except to the extent required by law, Adamis expressly disclaims any obligation to update any forward-looking statements.

Contacts:

Mark Flather
Senior Director, Investor Relations
& Corporate Communications
Adamis Pharmaceuticals Corporation
(858) 412-7951
mflather@adamispharma.com

$NTNX to Present at Upcoming Investor Conferences

SAN JOSE, Calif.

Nutanix (NASDAQ: NTNX), a leader in enterprise cloud computing, today announced that its management will be presenting at the following upcoming financial community events:

• Raymond James Technology Investors Conference
  New York, New York
  Monday, December 4, 2017
  1:15 p.m. EST; 10:15 a.m. PST

• 2017 Wells Fargo Tech Summit
  Park City, Utah
  Wednesday December 6, 2017
  11:00 a.m. MST; 1:00 p.m. EST; 10:00 a.m. PST

A live audio webcast and replay of each presentation will be accessible on the Nutanix Investor Relations website at: ir.nutanix.com.

About Nutanix

Nutanix makes infrastructure invisible, elevating IT to focus on the applications and services that power their business. The Nutanix Enterprise OS Cloud Software leverages web-scale engineering and consumer-grade design to natively converge compute, virtualization and storage into a resilient, software-defined solution with rich machine intelligence. The result is predictable performance, cloud-like infrastructure consumption, robust security, and seamless application mobility for a broad range of enterprise applications and services. Learn more at www.nutanix.com or follow us on Twitter @nutanix.

© 2017 Nutanix, Inc. All rights reserved. Nutanix, the Enterprise Cloud Platform, and the Nutanix logo are trademarks of Nutanix, Inc., registered or pending registration in the United States and other countries. All other brand names mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s).

Media Contact
Nutanix, Inc.
Tonya Chin, (408) 505-4637
tonya@nutanix.com

$GEOS Lemelson Capital Management Announces 10 Percent Stake

Firm reiterates near-term intrinsic value at $38 per share

MARLBOROUGH, Mass., Dec. 1, 2017 — Lemelson Capital Management, LLC, a private investment management firm, announced today it has acquired, for its flagship Amvona Fund, LP, a stake of approximately 10 percent in shares of Geospace Technologies (NASDAQ: GEOS), a global leader in the design and manufacture of instruments and equipment used by the oil and gas industry. In addition, it is urging the company to initiate an immediate share repurchase plan.

“With oil prices at a two-year high and rising and an agreement by OPEC and other major producers to extend output curbs until the end of 2018, the market continues to radically under-value Geospace Technologies. This overlooks the firm’s technological leadership—the company’s state-of-the-art GCL and GSX product lines have no competitive analogue; as well as its $75 million in liquidity, understated assets, zero-debt balance sheet and substantial revenue growth,” said Fr. Emmanuel Lemelson, Chief Investment Officer of Lemelson Capital Management.

With revenue in the fourth quarter increasing 45% over last year’s fourth quarter and representing the highest quarterly revenue in more than two years, a near 15-fold year-over-year increase in sales of the company’s market-leading GSX wireless recording system, a 61 percent increase in wireless product revenue in 2017 compared to fiscal year 2016 and operating income associated with the company’s non-seismic products increasing each year over the last three consecutive years, Lemelson Capital Management believes the near-term intrinsic value of Geospace Technologies common stock to be at least $38 per share.¹

“Geospace Technologies continues to experience significant increases in revenues and liquidity as evidenced by the more than $10 million in cash provided by operating activities in fiscal year 2017,” Lemelson added. “We believe the company’s non-cash charges², including aggressive inventory write-downs and subsequent sales of these same depreciated inventories at significant profits represent a tremendous store of shareholder value which is not reflected on the company’s balance sheet and points to the need for an immediate and aggressive share buyback program.”

Lemelson Capital today also released a copy of a recent letter sent to the company’s board of directors regarding this and other proposed actions. A copy of the letter can be found here: https://www.scribd.com/document/355452065/Letter-to-Gary-Owen-BoD-Geospace-Technologies-Corporation-NASDAQ-GEOS

About Lemelson Capital Management

Lemelson Capital Management, LLC is a private investment management firm focused on deep value and special situation investments. For more information, see: http://www.lemelsoncapital.com

For further information, please contact:

Media and Public Relations
Lemelson Capital Management, LLC

Telephone: 508-630-2281

SPECIAL NOTE REGARDING THIS RELEASE

THIS REPORT INCLUDES INFORMATION BASED ON DATA FOUND IN FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION, INDEPENDENT INDUSTRY PUBLICATIONS AND OTHER SOURCES. ALTHOUGH WE BELIEVE THAT THE DATA IS RELIABLE, WE HAVE NOT SOUGHT, NOR HAVE WE RECEIVED, PERMISSION FROM ANY THIRD-PARTY TO INCLUDE THEIR INFORMATION IN THIS PRESENTATION. MANY OF THE STATEMENTS IN THIS PRESENTATION REFLECT OUR SUBJECTIVE BELIEF.

EMMANUEL LEMELSON’S VIEWS AND HIS HOLDINGS OF THE SECURITIES MENTIONED IN THIS RELEASE COULD CHANGE AT ANY TIME. HE MAY SELL ANY OR ALL OF HIS HOLDINGS OR INCREASE HIS HOLDINGS BY PURCHASING ADDITIONAL SECURITIES. HE MAY TAKE ANY OF THESE OR OTHER ACTIONS REGARDING ANY OF SUCH SECURITIES WITHOUT UPDATING THIS RELEASE OR PROVIDING ANY NOTICE WHATSOEVER OF ANY SUCH CHANGES.

THE INFORMATION CONTAINED ABOVE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF GEOSPACE TECHNOLOGIES MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED ABOVE SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN DECISIONS REGARDING GEOSPACE TECHNOLOGIES AND ITS PROSPECTS BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICALLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED ABOVE. NEITHER LEMELSON CAPITAL MANAGEMENT, LLC NOR ANY OF ITS AFFILIATES ACCEPTS ANY LIABILITY WHATSOEVER FOR ANY DIRECT OR CONSEQUENTIAL LOSS HOWSOEVER ARISING, DIRECTLY OR INDIRECTLY, FROM ANY USE OF THE INFORMATION CONTAINED ABOVE.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this letter are forward-looking statements including, but not limited to, statements that are predications of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties. Forward-looking statements are not guarantees of future performance or activities and are subject to many risks and uncertainties. Due to such risks and uncertainties, actual events or results or actual performance may differ materially from those reflected or contemplated in such forward-looking statements. Forward-looking statements can be identified by the use of the future tense or other forward-looking words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “should,” “may,” “will,” “objective,” “projection,” “forecast,” “management believes,” “continue,” “strategy,” “position” or the negative of those terms or other variations of them or by comparable terminology. Important factors that could cause actual results to differ materially from the expectations set forth in this letter include, among other things, the factors identified under the section entitled “Risk Factors” in Geospace Technologies Annual Report on Form 10-K for the year ended September 30, 2016. Such forward-looking statements should therefore be construed in light of such factors, and Lemelson Capital is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

¹ Lemelson Capital believes the intrinsic value of Geospace Technologies is likely in the $50 to $60 per share range over the next few years
² Non-cash adjustments for inventory obsolescence and impairment charges on factory equipment alone  amounted to $26.8 million in fiscal year 2017

$CASI ENMD-2076 Poster Presentation at #SABCS, Triple-Negative Breast Cancer

ROCKVILLE, Md., Dec. 1, 2017  — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs announces a poster presentation on ENMD-2076 at the 2017 San Antonio Breast Cancer Symposium^TM (SABCS), December 5-9, 2017 in San Antonio, Texas.

ENMD-2076 is currently in a Phase 2 trial for the treatment of triple-negative breast cancer (TNBC) at two locations in the U.S. The poster will be presented in the session listed below and will be available on the CASI Pharmaceuticals website after the conclusion of the presentation.

Program Number: PD3-16
Abstract Number: 272
Session Title: Novel Drugs / Predicting Response for HER2+ Breast Cancer
Session Date: Thursday, December 7, 2017
Session Time: 7:00:00 AM – 9:00:00 AM CST
Title: “Clinical Safety and Efficacy of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated, Locally Advanced or Metastatic Triple-Negative Breast Cancer”

About CASI Pharmaceuticals, Inc.

CASI is a U.S. based, late-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a focus on commercialization in China. CASI’s product pipeline features (1) EVOMELA^®, MARQIBO^® and ZEVALIN^®, all U.S. Food and Drug Administration (FDA) approved drugs in-licensed from Spectrum Pharmaceuticals, Inc. for China regional rights, and currently in various stages in the regulatory and clinical process for market approval in China, (2) CASI-001 and CASI-002, proprietary preclinical candidates in immune-oncology, and (3) our proprietary drug candidate, ENMD-2076, ongoing in one Phase 2 clinical study. CASI is headquartered in Rockville, Maryland and has a wholly owned subsidiary and R&D operations in Beijing, China. More information on CASI is available at www.casipharmaceuticals.com and in CASI’s filings with the U.S. Securities and Exchange Commission.

CASI’s China rights to EVOMELA^® (melphalan) for Injection, MARQIBO^® (vinCRIStine sulfate LIPOSOME injection) and ZEVALIN^® (ibritumomab tiuxetan) were previously licensed from its partner Spectrum Pharmaceuticals, Inc. Based on the U.S. FDA’s approval of these three licensed products, CASI is pursuing the Import Drug registration path for approval in China.

Forward Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including: that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the volatility in the market price of our common stock; risks relating to interests of our largest stockholders that differ from our other stockholders; the risk of substantial dilution of existing stockholders in future stock issuances, the difficulty of executing our business strategy in China; our inability to predict when or if our product candidates will be approved for marketing by the China Food and Drug Administration authorities; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidates or future candidates; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; risks associated with our product candidates; risks associated with any early-stage products under development; the risk that results in preclinical and early clinical models are not necessarily indicative of later clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; the lack of success in the clinical development of any of our products; dependence on third parties; and risks relating to the commercialization, if any, of our proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks). Such factors, among others, could have a material adverse effect upon our business, results of operations and financial condition. We caution readers not to place undue reliance on any forward-looking statements, which only speak as of the date made. Additional information about the factors and risks that could affect our business, financial condition and results of operations, are contained in our filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.

EVOMELA^®, MARQIBO^® and ZEVALIN^® are proprietary to Spectrum Pharmaceuticals, Inc. and its affiliates.

$AMWD To Acquire Cabinet Manufacturer RSI Home Products

Accretive Acquisition Adds Highly Profitable Kitchen and Bath Cabinetry and Home Storage Brands to American Woodmark’s Growing Portfolio

WINCHESTER, Va., Dec. 1, 2017 — American Woodmark Corporation (NASDAQ: AMWD) (“American Woodmark”) today announced that it has entered into a definitive agreement and plan of merger with RSI Home Products, Inc. (“RSI”), a leading manufacturer of kitchen and bath cabinetry and home storage products.  Under the terms of the agreement, the implied enterprise value for RSI is approximately $1.075 billion, including $140 million in American Woodmark common stock to be issued to RSI shareholders (based on the most recent 5 trading day average closing price), approximately $346 million in net cash to be paid to RSI shareholders and approximately $589 million of RSI debt to be assumed by American Woodmark.  The cash portion of the consideration is subject to customary working capital adjustments.

Founded in 1989 by Ron Simon with a vision of creating exceptional value for customers by providing high quality products at affordable prices not otherwise available in the industry, RSI has grown to one of the largest in-stock and value-based cabinet makers in North America providing kitchen, bathroom, home and garage organization cabinetry, counter tops and accessories with over 100 styles and finishes to home centers, builders, dealers and remodeling contractors.  RSI expects to generate net income of over $40 million and adjusted EBITDA of over $120 million on approximately $560 million of revenue for its fiscal year ending December 31, 2017, representing an adjusted EBITDA margin of over 21%.

The acquisition is expected to be immediately accretive to American Woodmark’s profit margins and earnings per share (“EPS”), excluding transaction costs and before giving effect to anticipated synergies.  Although there can be no assurance, the transaction is expected to close in American Woodmark’s quarter that ends January 31, 2018, subject to antitrust regulatory review and approvals and other customary closing conditions.  The transaction does not require approval of American Woodmark shareholders and has already received approval from the RSI shareholders.

“RSI has built a tremendous reputation and position in our industry by delivering quality products at a compelling value position, and we are excited to welcome them to the American Woodmark family,” said Cary Dunston, American Woodmark’s Chairman and CEO.  “The acquisition of RSI will further enhance American Woodmark by creating a broader product and brand portfolio that is well-positioned to fully leverage our industry-leading service platform across all channels and to drive improved profitability and long-term value for shareholders.  RSI’s strong culture of continuous improvement with a relentless focus on innovation and reengineering throughout their operational and business practices complements our existing capabilities.  Most importantly, American Woodmark and RSI share a similar culture that rests soundly on a foundation of extraordinary employees and creating value through people.”

Alex Calabrese, RSI’s Chairman and CEO commented, “This is an exciting day for RSI and reflects the hard work and dedication of everyone involved in our proud history and success over the past 28 years, most specifically, our dedicated associates as well as our valued customers and suppliers.  We have great respect for American Woodmark, and are honored to be joining forces with a company that shares our culture, values and vision.  This shared foundation makes the two companies an ideal fit.   RSI looks forward to continuing its growth and delivering the highest value and best services to its customers.”

“We couldn’t be more excited and optimistic about the future potential for RSI and its loyal employee associates,” said Ron Simon, RSI’s Founder and current director.  “This merger creates a company that will be a stronger competitor in the kitchen and bath industry than RSI could be on its own.  The fact that the two companies share the same culture in the way they value their associates and customers will go a long way to ensure great future success.  We believe RSI is the industry’s lowest cost manufacturer, and American Woodmark has unmatched logistics and service capabilities, as well as a very broad product line.  This combination enables American Woodmark to bring the greatest value by making higher quality products affordable to more consumers.”

Transaction Highlights
(Pro forma metrics represent unaudited financial information)

• The combined company will have approximately $1.6 billion in pro forma annual revenue along with a broader product portfolio that is well-positioned to deliver growth, improved profitability and shareholder value.
• Annual run-rate synergies are anticipated to be $30-40 million, phased in over 3 years, to be achieved through identified opportunities in sales and marketing, purchasing and manufacturing efficiencies through the sharing of operational best practices.
• American Woodmark expects to fund the $346 million net cash payment and transaction fees and expenses with cash on hand and committed financing from Wells Fargo Bank, National Association. American Woodmark also expects to enter into a new $100 million revolving credit facility with Wells Fargo Bank, National Association to replace its existing revolver and, if necessary, may draw on such facility for any remaining cash payments for the transaction.
• Prior to the closing of the transaction, RSI intends to conduct a consent solicitation with respect to its 6 ¹/₂% Senior Secured Second Lien Notes 2023 (the “RSI Notes”) in order to amend the related indenture so that the change of control provisions contained therein will not apply to the transaction. In addition, American Woodmark expects to explore options to refinance the RSI Notes either in connection with or after the closing of the transaction.
• Immediately following the closing of the transaction, RSI shareholders will own approximately 8% of American Woodmark shares outstanding. These shares will be subject to a six-month lock up period.
• American Woodmark is suspending its share repurchase program in conjunction with the transaction.
• The combined company will be managed by American Woodmark’s management team (led by Chairman and CEO Cary Dunston).
• RSI will operate as a subsidiary of American Woodmark following the transaction with its existing brands, channel strategy and operational philosophy remaining.

The Company will host a conference call today with investors, December 1, 2017 at 11:00 EST.  A presentation, which will accompany the call, will be available at www.americanwoodmark.com and will remain available after the call.

Advisors:

Robert W. Baird & Co. Incorporated is serving as financial advisor and McGuireWoods LLP is serving as legal counsel to American Woodmark.  Intrepid Investment Bankers LLC is serving as financial advisor and O’Melveny & Myers LLP is serving as legal counsel to RSI.

About RSI Home Products, Inc.:

Since RSI Home Products, Inc. was founded in 1989 it has been a customer-focused, quality-driven manufacturer of bath, kitchen and home organization products throughout the U.S. and Canada.  The company has outpaced its competition and continues to offer high-quality, low-cost, value-rich products.  RSI Home Products employs more than 4,200 people and has manufacturing and distribution facilities in California, North Carolina, Texas, and Mexico. For more information, visit www.rsihomeproducts.com.

About American Woodmark Corporation:

American Woodmark Corporation manufactures and distributes kitchen cabinets and vanities for the remodeling and new home construction markets.  Its products are sold on a national basis directly to home centers, major builders and through a network of independent distributors.  The Company presently operates nine manufacturing facilities and seven service centers across the country. For more information, visit www.americanwoodmark.com.

Forward Looking Statements

This communication contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements as to the anticipated timing of completion of the proposed transaction, expected cost synergies, future financial and operating results, and other expected effects of the proposed transaction.  These forward-looking statements may be identified by the use of words such as “anticipate,” “estimate,” “forecast,” “expect,” “believe,” “should,” “could,” “would,” “plan,” “may,” ” intend,” “prospect,” “goal,” “will,” “predict,” or “potential” or other similar words or variations thereof.  These statements are based on the current beliefs and expectations of the management of American Woodmark and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially from those expressed herein.  These risks and uncertainties include, but are not limited to, the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement or a delay in the completion of the proposed transaction, a failure by either or both parties to satisfy conditions to closing, a failure to obtain any required regulatory or third-party approvals, including any required antitrust approvals, risks associated with the financing of the transaction, the effect of the announcement of the proposed transaction on the ability of American Woodmark and RSI to retain customers, maintain relationships with their suppliers and hire and retain key personnel, American Woodmark’s ability to successfully integrate RSI into its business and operations, and the risk that the economic benefits, costs savings and other synergies anticipated by American Woodmark are not fully realized or take longer to realize than expected.  Additional risks and uncertainties that could impact American Woodmark’s future operations and financial results are contained in American Woodmark’s filings with the Securities and Exchange Commission (“SEC”), including in its Annual Report on Form 10-K for the year ended April 30, 2017 under the heading “Risk Factors” and its most recent Quarterly Report on Form 10-Q for the period ended July 31, 2017 under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward Looking Statements.”  These reports, as well as the other documents filed by American Woodmark with the SEC, are available free of charge at the SEC’s website at www.sec.gov.

Non-GAAP Reconciliation

The following information provides reconciliations of non-GAAP financial measures from operations, which are presented in the accompanying presentation, to the most comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).  Each company has provided non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in the accompanying presentation that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for, or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the presentation.  The non-GAAP financial measures in the accompanying presentation may differ from similar measures used by other companies.  The following tables reconcile the non-GAAP measure of Earnings Before Interest, Taxes, Depreciation and Amortization, as adjusted (“Adjusted EBITDA”) referred to in this presentation to the most directly comparable GAAP measure reflected in each company’s financial statements.

_______________________

Note: Adjusted EBITDA defined as operating income plus depreciation and amortization and impact of certain non-recurring / non-cash items not considered to be part of normal operations.

Note:  the estimated financial numbers for RSI and American Woodmark provided above represent estimates by RSI’s management and American Woodmark’s management, respectively, as of the date of this release only and (i) are based upon a number of assumptions and estimates that are inherently subject to business, economic and competitive uncertainties and contingencies, many of which are beyond our control, (ii) are based upon certain specific assumptions with respect to future business decisions, some of which will change, and (iii) are necessarily speculative in nature.   Some or all of the assumptions and estimates utilized may not materialize or may vary significantly from actual results.   As a result, investors are urged to put the estimated numbers provided in context and not to place undue reliance on them.